BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30799288)

  • 1. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes.
    Thompson PJ; Shah A; Ntranos V; Van Gool F; Atkinson M; Bhushan A
    Cell Metab; 2019 May; 29(5):1045-1060.e10. PubMed ID: 30799288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage to β cells in culture recapitulates features of senescent β cells that accumulate in type 1 diabetes.
    Brawerman G; Pipella J; Thompson PJ
    Mol Metab; 2022 Aug; 62():101524. PubMed ID: 35660116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BET Proteins Are Required for Transcriptional Activation of the Senescent Islet Cell Secretome in Type 1 Diabetes.
    Thompson PJ; Shah A; Apostolopolou H; Bhushan A
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha cell dysfunction in type 1 diabetes is independent of a senescence program.
    Brawerman G; Ntranos V; Thompson PJ
    Front Endocrinol (Lausanne); 2022; 13():932516. PubMed ID: 36277717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies.
    Bogenberger JM; Delman D; Hansen N; Valdez R; Fauble V; Mesa RA; Tibes R
    Leuk Lymphoma; 2015 Jan; 56(1):226-9. PubMed ID: 24707940
    [No Abstract]   [Full Text] [Related]  

  • 6. Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production.
    Zhan Y; Carrington EM; Ko HJ; Vikstrom IB; Oon S; Zhang JG; Vremec D; Brady JL; Bouillet P; Wu L; Huang DC; Wicks IP; Morand EF; Strasser A; Lew AM
    Arthritis Rheumatol; 2015 Mar; 67(3):797-808. PubMed ID: 25418983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired immune surveillance accelerates accumulation of senescent cells and aging.
    Ovadya Y; Landsberger T; Leins H; Vadai E; Gal H; Biran A; Yosef R; Sagiv A; Agrawal A; Shapira A; Windheim J; Tsoory M; Schirmbeck R; Amit I; Geiger H; Krizhanovsky V
    Nat Commun; 2018 Dec; 9(1):5435. PubMed ID: 30575733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
    Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
    Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 inhibitors reduce steroid-insensitive airway inflammation.
    Tian BP; Xia LX; Bao ZQ; Zhang H; Xu ZW; Mao YY; Cao C; Che LQ; Liu JK; Li W; Chen ZH; Ying S; Shen HH
    J Allergy Clin Immunol; 2017 Aug; 140(2):418-430. PubMed ID: 28043871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
    Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
    Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL.
    Yosef R; Pilpel N; Tokarsky-Amiel R; Biran A; Ovadya Y; Cohen S; Vadai E; Dassa L; Shahar E; Condiotti R; Ben-Porath I; Krizhanovsky V
    Nat Commun; 2016 Apr; 7():11190. PubMed ID: 27048913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes.
    Dooley J; Tian L; Schonefeldt S; Delghingaro-Augusto V; Garcia-Perez JE; Pasciuto E; Di Marino D; Carr EJ; Oskolkov N; Lyssenko V; Franckaert D; Lagou V; Overbergh L; Vandenbussche J; Allemeersch J; Chabot-Roy G; Dahlstrom JE; Laybutt DR; Petrovsky N; Socha L; Gevaert K; Jetten AM; Lambrechts D; Linterman MA; Goodnow CC; Nolan CJ; Lesage S; Schlenner SM; Liston A
    Nat Genet; 2016 May; 48(5):519-27. PubMed ID: 26998692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR signaling orchestrates the expression of cytoprotective factors during cellular senescence.
    Yosef R; Krizhanovsky V
    Oncotarget; 2016 Aug; 7(31):48859. PubMed ID: 27447572
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
    PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICAM-1 Abundance Is Increased in Pancreatic Islets of Hyperglycemic Female NOD Mice and Is Rapidly Upregulated by NF-κB in Pancreatic β-Cells.
    Martin TM; Burke SJ; Batdorf HM; Burk DH; Ghosh S; Dupuy SD; Karlstad MD; Collier JJ
    J Immunol; 2022 Aug; 209(3):569-581. PubMed ID: 35851539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
    Shahbandi A; Rao SG; Anderson AY; Frey WD; Olayiwola JO; Ungerleider NA; Jackson JG
    Cell Death Differ; 2020 Nov; 27(11):3097-3116. PubMed ID: 32457483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced regulatory T cells suppress Tc1 cells through TGF-β signaling to ameliorate STZ-induced type 1 diabetes mellitus.
    Zhou L; He X; Cai P; Li T; Peng R; Dang J; Li Y; Li H; Huang F; Shi G; Xie C; Lu Y; Chen Y
    Cell Mol Immunol; 2021 Mar; 18(3):698-710. PubMed ID: 33446887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma.
    Gonzalez-Meljem JM; Haston S; Carreno G; Apps JR; Pozzi S; Stache C; Kaushal G; Virasami A; Panousopoulos L; Mousavy-Gharavy SN; Guerrero A; Rashid M; Jani N; Goding CR; Jacques TS; Adams DJ; Gil J; Andoniadou CL; Martinez-Barbera JP
    Nat Commun; 2017 Nov; 8(1):1819. PubMed ID: 29180744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.